Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting
Peptide development is rarely straightforward. From insoluble sequences and impurity challenges to extended development timelines and regulatory hurdles, each step can introduce delays and risks that threaten your drug development program.
Whether you’re working with small molecule peptides, SPPS, LPPS, or hybrid approaches, our integrated capabilities ensure: scalable and reproducible synthesis, rigorous impurity profiling and control, accelerated development timelines, and regulatory-ready documentation and compliance.
Neuland’s custom peptide synthesis services cover all the pharmaceutical and biotech industry’s peptide requirements. We specialize in the clinical development of simple to complex peptides synthesis and their commercial-scale manufacturing.
Custom synthesis, route scouting, process development and validation, and impurity detection to ensure feasibility and optimization
Comprehensive manufacturing solutions across scale - from clinical trial batches to full- scale commercial production of complex amino acids and FMOC-building blocks.
Advanced R&D capabilities, including method validation, impurity profiling, and stability studies, supported by analytical reference standards.
Raw material vendor evaluation and qualification, ensuring seamless scale-up across lab production, pilots, and commercial manufacturing.
CMC preparation and review for peptide APIs, ensuring regulatory compliance with IMPD, IND, NDA, and ANDA registrations.